EMA — authorised 24 June 2022
- Marketing authorisation holder: GENZYME EUROPE BV
- Status: approved
EMA authorised Neogaa on 24 June 2022
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. EMA authorised it on 24 June 2022.
GENZYME EUROPE BV holds the EU marketing authorisation.